tiprankstipranks
Novartis’s treatment of leishmaniasis granted FDA orphan designation
PremiumThe FlyNovartis’s treatment of leishmaniasis granted FDA orphan designation
8d ago
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
Premium
Market News
Patient Fatality Forces Reality Check on Sarepta Therapeutics Stock (SRPT)
9d ago
Novartis announces results from Phase III program for OAV101 IT
Premium
The Fly
Novartis announces results from Phase III program for OAV101 IT
9d ago
Novartis holder Emasan selling 26.5M shares, Bloomberg reports
PremiumThe FlyNovartis holder Emasan selling 26.5M shares, Bloomberg reports
1M ago
Emasan files to sell 26.5M shares of Novartis, Bloomberg reports
Premium
The Fly
Emasan files to sell 26.5M shares of Novartis, Bloomberg reports
1M ago
Amgen (NASDAQ:AMGN) to Invest $200M in India High Tech Site as Trump Tariffs Loom 
Premium
Market News
Amgen (NASDAQ:AMGN) to Invest $200M in India High Tech Site as Trump Tariffs Loom 
1M ago
Novartis agrees to acquire Anthos for up to $3.1B
PremiumThe FlyNovartis agrees to acquire Anthos for up to $3.1B
2M ago
Hold Rating for Novartis AG Due to Limited Potential of Abelacimab Despite Acquisition of Anthos Therapeutics
Premium
Ratings
Hold Rating for Novartis AG Due to Limited Potential of Abelacimab Despite Acquisition of Anthos Therapeutics
2M ago
M&A News: Novartis Seals $3.1B Deal to Acquire Anthos
Premium
Market News
M&A News: Novartis Seals $3.1B Deal to Acquire Anthos
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100